HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

HENGRUI PHARMA

45.000

+1.2402.83%

Volume:3.12M

Turnover:139.22M

Market Cap:298.67B

PE:32.61

High:45.400

Open:43.700

Low:43.020

Close:43.760

52wk High:94.869

52wk Low:43.020

Shares:6.64B

HK Float Shares:258.00M

Volume Ratio:1.05

T/O Rate:1.21%

Dividend:0.23

Dividend Rate:0.52%

EPS(LYR):1.380

ROE:12.46%

ROA:7.02%

PB:3.96

PE(LYR):32.61

PS:8.15

Loading ...

Overview Company News Filings

Update: Hengrui Pharma Unit Secures China Nod For Diabetes Drug Application

MT Newswires Live

Hengrui Pharma's HRS-7535 Tablet Marketing Authorization Application Accepted by China's NMPA

Hengrui Pharma Has Not Yet Initiated Its A-Share Buyback Program as of End-August

Jiangsu Hengrui's Subsidiary Receives Regulatory Nod for Diabetes Drug Application

Movement Alert｜HENGRUI PHARMA Falls 3.05% in Regular Trading, Mid-Year Earnings Under Pressure Amid Broad Pharma Sector Weakness

Hengrui Pharma's Interim Report Falls Flat: Legacy Blockbusters Fade as Revenue Posts First Half-Year Decline in Four Years

Movement Alert｜HENGRUI PHARMA Rises 3.04% in Regular Trading, GIC Private Limited Consecutively Increases Stake to 17.19%

Singapore Sovereign Fund Boosts Stake in Chinese Drugmaker with HK$185 Million Share Purchase

JPMorgan Chase & Co.'S Short Position in H-Shares of Jiangsu Hengrui Pharmaceuticals Co., Ltd. Increases to 3.72% on August 21 from 2.57% - HKEX

THOMSON REUTERS

Singapore's GIC Boosts Stake in Hengrui Pharma With HK$185 Million Share Purchase

HENGRUI PHARMA: GIC Private Limited Acquires Shares, Long Position Rises to 15.7%

Chinese Drug Regulator Accepts Hengrui Pharma's Drug Marketing Application for HRG2010 Capsules

MT Newswires Live

HENGRUI PHARMA's HRG2010 Capsule Marketing Application Accepted by NMPA

Nomura Adjusts Jiangsu Hengrui Pharmaceuticals' Price Target to HK$82.18 From HK$87.49, Keeps at Buy

MT Newswires Live

Hengrui Pharma's Half-Year Report: Heavy Spending Fails to Drive Growth as Former Sector Leader Struggles with Revenue Without Profit Expansion

Movement Alert｜HENGRUI PHARMA Falls 3.03% in Regular Trading, BOCOM International Cuts Target Price Citing Continued Pressure on Legacy Products

Hengrui Pharma's Growth Architecture Shifts: Second Growth Engine Accelerates as Global Valuation Framework Expands

Hengrui Pharma Gets Nod to Trial SHR-8203 Injection

MT Newswires Live

Hengrui Pharma Unit Gets China Nod for Lupus Drug Trial

MT Newswires Live

Movement Alert｜HENGRUI PHARMA Declines 3.18% in Regular Trading, Extending Sell-Off on Weak H1 Earnings Quality

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/stock/01276/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"01276","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01276\",,,,,undefined,":{"symbol":"01276","market":"HK","secType":"STK","nameCN":"HENGRUI PHARMA","latestPrice":45,"timestamp":1789373284003,"preClose":43.76,"halted":0,"volume":3121200,"delay":0,"changeRate":0.028336380255941547,"floatShares":258000000,"shares":6637000000,"eps":1.3797518275656513,"marketStatus":"Closed","change":1.24,"latestTime":"09-14 16:08:04","open":43.7,"high":45.4,"low":43.02,"amount":139223220,"amplitude":0.054388,"askPrice":45,"askSize":33800,"bidPrice":44.94,"bidSize":8800,"shortable":3,"etf":0,"ttmEps":1.3606808510337902,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789435800000},"marketStatusCode":5,"adr":0,"listingDate":1747929600000,"exchange":"SEHK","adjPreClose":43.76,"dividendRate":0.005185,"openAndCloseTimeList":[[1789349400000,1789358400000],[1789362000000,1789372800000]],"volumeRatio":1.0522,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"600276","market":"SH","secType":"STK","nameCN":"Jiangsu Hengrui Pharmaceuticals Co.,Ltd.","latestPrice":43.15,"timestamp":1789369200000,"preClose":42.67,"halted":0,"volume":52623200,"delay":0,"premium":"-10.81"}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01276\",,,,,undefined,":{"symbol":"01276","floatShares":258000000,"roa":"7.02%","roe":"12.46%","lyrEps":1.379752,"volumeRatio":1.0522,"shares":6637000000,"dividePrice":0.233856,"high":45.4,"amplitude":0.054388,"preClose":43.76,"low":43.02,"week52Low":43.02,"pbRate":"3.96","psRate":"8.15","week52High":94.869,"institutionHeld":0,"latestPrice":45,"committee":-0.586854,"eps":1.3797518275656513,"divideRate":0.005197,"volume":3121200,"delay":0,"ttmEps":1.3606808510337902,"open":43.7,"prevYearClose":71.002,"prevWeekClose":43.76,"prevMonthClose":46.06,"prevQuarterClose":57.85,"fiveDayClose":46.94,"twentyDayClose":53.7,"sixtyDayClose":54.65},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/01276\",params:#limit:5,,,undefined,":[{"date":"2026-08-19","symbol":"01276","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787103000000,"name":null,"time":"","dateTimestamp":1787068800000,"actualEps":null},{"date":"2026-04-29","symbol":"01276","amount":0.22828,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"HK","newRecordDate":"2026-04-30","defaultRemindTime":1777426200000,"name":"恒瑞医药","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-05-27","payableDate":"2026-04-30","currency":"HKD","dateTimestamp":1777392000000,"payDate":"2026-05-27"},{"date":"2026-04-22","symbol":"01276","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1776821400000,"name":null,"time":"","dateTimestamp":1776787200000,"actualEps":null},{"date":"2026-03-26","symbol":"01276","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774488600000,"name":null,"time":"","dateTimestamp":1774454400000,"actualEps":null},{"date":"2025-10-28","symbol":"01276","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1761615000000,"name":null,"time":"","dateTimestamp":1761580800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"01276\",market:\"HK\",,,undefined,":[{"executeDate":"2026-04-29","recordDate":"2026-04-30","paymentDate":"2026-05-27","value":0.22828,"currency":"HKD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"01276\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.2727,"buy":0.5455,"hold":0.1818,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5455,"analysts":11,"updateTime":1786723200000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/01276\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"01276","date":"2026-09-11","current":33.026663,"percent":0,"low":36.382401,"twenty":43.912617,"median":51.717719,"eighty":57.022157,"high":65.582363,"avg":51.204736,"sd":7.389609,"marketCap":328426636361.34},"quantilePoints":[{"date":"2025-05-23","current":52.570963,"twenty":52.783176,"median":53.101495,"eighty":53.419815,"marketCap":390693388207.53},{"date":"2025-05-30","current":53.015805,"twenty":51.822085,"median":52.540895,"eighty":52.926837,"marketCap":395731540422.24},{"date":"2025-06-06","current":52.120101,"twenty":52.130014,"median":52.555929,"eighty":53.075252,"marketCap":390038198012.59},{"date":"2025-06-13","current":52.209491,"twenty":52.177631,"median":52.691227,"eighty":53.357137,"marketCap":390861633032.23},{"date":"2025-06-20","current":50.172412,"twenty":51.591196,"median":52.469796,"eighty":53.075252,"marketCap":374874997562.85},{"date":"2025-06-27","current":50.314776,"twenty":50.363569,"median":52.169666,"eighty":53.013533,"marketCap":376991477472.78},{"date":"2025-07-04","current":51.666141,"twenty":50.343584,"median":52.120101,"eighty":53.004446,"marketCap":387134991658.26},{"date":"2025-07-11","current":55.507007,"twenty":50.44351,"median":52.13337,"eighty":53.090114,"marketCap":415495681161.23},{"date":"2025-07-18","current":57.272274,"twenty":50.582121,"median":52.209491,"eighty":54.057606,"marketCap":428373566715.29},{"date":"2025-07-25","current":54.897923,"twenty":50.594414,"median":52.555929,"eighty":55.711415,"marketCap":412107620053.2},{"date":"2025-08-01","current":59.731878,"twenty":50.855059,"median":52.994419,"eighty":55.972407,"marketCap":445624526286.47},{"date":"2025-08-08","current":59.478715,"twenty":51.107295,"median":53.05296,"eighty":56.541585,"marketCap":444845815775.64},{"date":"2025-08-15","current":61.917611,"twenty":51.356483,"median":53.519848,"eighty":59.478715,"marketCap":462392609292.46},{"date":"2025-08-22","current":58.782188,"twenty":51.569512,"median":54.477764,"eighty":60.15932,"marketCap":470428104569.66},{"date":"2025-08-29","current":59.85298,"twenty":51.666141,"median":55.691374,"eighty":59.937003,"marketCap":481284287403.35},{"date":"2025-09-05","current":65.582363,"twenty":51.677932,"median":55.770266,"eighty":60.732448,"marketCap":526832269752.24},{"date":"2025-09-12","current":62.481332,"twenty":51.8337,"median":55.972407,"eighty":61.285609,"marketCap":502824785657.99},{"date":"2025-09-19","current":63.179889,"twenty":52.120101,"median":56.254853,"eighty":61.852995,"marketCap":508085671393.42},{"date":"2025-09-26","current":63.528382,"twenty":52.146639,"median":56.965096,"eighty":62.270337,"marketCap":509562668601.01},{"date":"2025-10-03","current":64.989073,"twenty":52.165061,"median":57.272274,"eighty":62.504861,"marketCap":522523002865.02},{"date":"2025-10-10","current":61.782766,"twenty":52.193561,"median":59.039802,"eighty":62.657943,"marketCap":496019912951.91},{"date":"2025-10-17","current":58.903713,"twenty":52.323014,"median":59.170669,"eighty":62.619084,"marketCap":472537436949.31},{"date":"2025-10-24","current":59.187086,"twenty":52.484015,"median":59.039802,"eighty":62.52839,"marketCap":474983377696.11},{"date":"2025-10-31","current":57.072441,"twenty":52.552922,"median":59.021138,"eighty":62.417499,"marketCap":465758305542.93},{"date":"2025-11-07","current":54.713071,"twenty":52.619069,"median":58.881843,"eighty":62.304573,"marketCap":446224987036.64},{"date":"2025-11-14","current":55.883072,"twenty":52.812504,"median":58.231971,"eighty":62.27542,"marketCap":457058673340.29},{"date":"2025-11-21","current":52.805265,"twenty":52.880927,"median":57.030538,"eighty":62.209511,"marketCap":431684582485.14},{"date":"2025-11-28","current":55.237621,"twenty":52.99843,"median":56.630614,"eighty":62.069705,"marketCap":453209419829.34},{"date":"2025-12-05","current":54.841023,"twenty":53.00899,"median":56.437545,"eighty":61.965159,"marketCap":450729029423.46},{"date":"2025-12-12","current":56.212257,"twenty":53.045529,"median":56.385682,"eighty":61.891765,"marketCap":462853512587.19},{"date":"2025-12-19","current":54.083493,"twenty":53.045529,"median":56.227363,"eighty":61.831221,"marketCap":446374731108.34},{"date":"2025-12-24","current":54.414957,"twenty":53.090114,"median":56.103073,"eighty":61.798561,"marketCap":450509359276.9},{"date":"2026-01-02","current":53.078544,"twenty":53.065996,"median":55.972407,"eighty":61.785925,"marketCap":441174507319.22},{"date":"2026-01-09","current":56.743223,"twenty":53.0878,"median":56.0944,"eighty":61.695241,"marketCap":472808676524.34},{"date":"2026-01-16","current":55.187351,"twenty":53.304215,"median":56.103073,"eighty":61.405393,"marketCap":461338821289.95},{"date":"2026-01-23","current":52.546341,"twenty":53.0878,"median":56.076447,"eighty":61.296167,"marketCap":438839874056.97},{"date":"2026-01-30","current":51.677141,"twenty":52.994149,"median":55.908509,"eighty":61.278475,"marketCap":433553740508.2},{"date":"2026-02-06","current":50.918226,"twenty":52.680723,"median":55.839154,"eighty":61.101743,"marketCap":428270226283.58},{"date":"2026-02-13","current":51.771686,"twenty":52.512455,"median":55.711415,"eighty":60.890064,"marketCap":437949787160.49},{"date":"2026-02-20","current":51.752043,"twenty":52.351169,"median":55.691374,"eighty":60.824953,"marketCap":437153052005.04},{"date":"2026-02-27","current":50.215456,"twenty":52.151244,"median":55.507566,"eighty":60.720339,"marketCap":428825318404.97},{"date":"2026-03-06","current":49.335298,"twenty":51.80347,"median":55.280584,"eighty":60.654676,"marketCap":417912584744.19},{"date":"2026-03-13","current":48.90444,"twenty":51.75217,"median":55.201025,"eighty":60.572606,"marketCap":416170839186.33},{"date":"2026-03-20","current":48.948437,"twenty":51.671435,"median":55.086674,"eighty":60.515374,"marketCap":414967977646.95},{"date":"2026-03-27","current":47.483832,"twenty":51.400677,"median":54.94883,"eighty":60.443129,"marketCap":414588875872.42},{"date":"2026-04-02","current":49.302243,"twenty":51.107295,"median":54.905743,"eighty":60.227005,"marketCap":432534434303.11},{"date":"2026-04-10","current":49.055344,"twenty":50.995993,"median":54.897923,"eighty":60.186394,"marketCap":433687668394.36},{"date":"2026-04-17","current":48.417764,"twenty":50.589497,"median":54.65026,"eighty":60.143018,"marketCap":428230701835.75},{"date":"2026-04-24","current":45.835792,"twenty":50.342877,"median":54.475147,"eighty":60.015062,"marketCap":426879682872.04},{"date":"2026-04-30","current":44.026312,"twenty":50.285416,"median":54.355253,"eighty":59.903394,"marketCap":410132737659.64},{"date":"2026-05-08","current":43.161515,"twenty":50.207478,"median":54.262074,"eighty":59.804539,"marketCap":403472171949.3},{"date":"2026-05-15","current":44.128138,"twenty":49.985706,"median":54.115335,"eighty":59.70386,"marketCap":413593092820.6},{"date":"2026-05-22","current":41.244553,"twenty":49.583265,"median":53.983854,"eighty":59.631568,"marketCap":385683097978.4},{"date":"2026-05-29","current":40.98659,"twenty":49.34142,"median":53.840414,"eighty":59.564678,"marketCap":384603594259.51},{"date":"2026-06-05","current":38.394132,"twenty":49.063316,"median":53.633194,"eighty":59.459458,"marketCap":360799766229.36},{"date":"2026-06-12","current":39.515262,"twenty":48.81081,"median":53.517715,"eighty":59.36625,"marketCap":371084155232.86},{"date":"2026-06-18","current":39.444808,"twenty":48.417764,"median":53.467699,"eighty":59.301536,"marketCap":371311256576.18},{"date":"2026-06-26","current":39.60241,"twenty":47.951326,"median":53.090114,"eighty":59.187086,"marketCap":370974287810.31},{"date":"2026-07-03","current":44.319925,"twenty":47.638943,"median":53.015805,"eighty":59.069259,"marketCap":415476044901.86},{"date":"2026-07-10","current":45.319748,"twenty":47.348429,"median":52.993744,"eighty":59.024871,"marketCap":424327469311.14},{"date":"2026-07-17","current":43.189222,"twenty":46.151454,"median":52.805265,"eighty":58.96135,"marketCap":405818502739.33},{"date":"2026-07-24","current":43.433009,"twenty":45.632553,"median":52.604835,"eighty":58.912251,"marketCap":408200902707.63},{"date":"2026-07-31","current":43.935338,"twenty":45.29749,"median":52.543618,"eighty":58.877468,"marketCap":413706414238.87},{"date":"2026-08-07","current":44.394532,"twenty":45.008473,"median":52.339287,"eighty":58.813302,"marketCap":418841988303.56},{"date":"2026-08-14","current":42.6704,"twenty":44.628794,"median":52.189578,"eighty":58.452058,"marketCap":403085247281.44},{"date":"2026-08-21","current":40.686911,"twenty":44.408765,"median":52.120101,"eighty":57.75211,"marketCap":366558497066.13},{"date":"2026-08-28","current":40.334802,"twenty":44.24321,"median":51.814807,"eighty":57.336246,"marketCap":363468645736.13},{"date":"2026-09-04","current":39.220129,"twenty":44.050964,"median":51.771686,"eighty":57.152374,"marketCap":353565883607.49},{"date":"2026-09-11","current":36.382401,"twenty":43.912617,"median":51.717719,"eighty":57.022157,"marketCap":328426636361.34}],"updateTime":1789371276806},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"01276\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664818823","title":"Update: Hengrui Pharma Unit Secures China Nod For Diabetes Drug Application","url":"https://stock-news.laohu8.com/highlight/detail?id=2664818823","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664818823?lang=en_us&edition=fundamental","pubTime":"2026-09-03 10:24","pubTimestamp":1788402243,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals  unit Shandong Shengdi received regulatory acceptance in China for the marketing application of its HRS-7535 tablets.The drug is indicated for blood sugar control in patients with type two diabetes mellitus, according to a Wednesday aftermarket filing with the Shanghai bourse.Shares of the company were up 1% in recent trade.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0359201612.USD","LU2543165471.USD","BK1191","LU0359202008.SGD","LU0359201885.HKD","LU1023057109.AUD","01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125110251","title":"Hengrui Pharma's HRS-7535 Tablet Marketing Authorization Application Accepted by China's NMPA","url":"https://stock-news.laohu8.com/highlight/detail?id=1125110251","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125110251?lang=en_us&edition=fundamental","pubTime":"2026-09-02 18:22","pubTimestamp":1788344549,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals Co., Ltd. (HENGRUI PHARMA) has announced that its subsidiary, Shandong Shengdi Pharmaceutical Co., Ltd., recently received the \"Acceptance Notice\" from China's...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1064130708.USD","IPOS","600276","LU1580142542.USD","LU2580892862.HKD","BK0183","LU1064131003.USD","BK1191","LU2495084118.USD","BK0012","BK0188","LU2580892789.USD","LU1146622755.USD","LU2097828474.EUR","LU0405327494.USD","LU1328615791.USD","LU2097828631.EUR","LU2328871848.SGD","LU1997245094.SGD","LU2097828714.EUR","LU2543165471.USD","BK0239","LU2488822045.USD","01276","LU1023057109.AUD","LU1655091616.SGD","LU1820825898.SGD","LU0359202008.SGD","LU0405327148.USD","BK0028","LU1781817850.SGD","LU0359201612.USD","LU2148510915.USD","LU1969619763.USD","LU2289578879.USD","LU2097828805.USD","LU1997244956.HKD","BK0060","BK0196","LU2097828557.USD","LU0359201885.HKD","LU1255011170.USD","LU1997245177.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150175257","title":"Hengrui Pharma Has Not Yet Initiated Its A-Share Buyback Program as of End-August","url":"https://stock-news.laohu8.com/highlight/detail?id=1150175257","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150175257?lang=en_us&edition=fundamental","pubTime":"2026-09-02 17:16","pubTimestamp":1788340577,"startTime":"0","endTime":"0","summary":"Hengrui Pharma (01276) has issued an announcement revealing that, as of August 31, 2026, the company has not yet started implementing its share repurchase plan.According to the disclosure, as of the...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1997244956.HKD","02846","83188","LU2097828557.USD","LU2097828631.EUR","BK0188","83130","LU2328871848.SGD","01276","LU1580142542.USD","399300","LU1820825898.SGD","LU1255011170.USD","LU1064130708.USD","LU1023057109.AUD","LU1328615791.USD","LU0405327494.USD","BK0196","LU2148510915.USD","02827","LU0359201612.USD","LU2580892789.USD","LU1064131003.USD","LU0359201885.HKD","LU0359202008.SGD","LU1969619763.USD","LU2543165471.USD","LU1997245094.SGD","LU2289578879.USD","07233","600276","LU1781817850.SGD","BK1191","LU2488822045.USD","LU1655091616.SGD","LU2097828474.EUR","03130","82846","BK0012","BK0060","LU2580892862.HKD","BK1147","BK0183","LU2097828714.EUR","03188","BK0028","LU1146622755.USD","LU1997245177.USD","LU2495084118.USD","BK0239","159982","LU2097828805.USD","LU0405327148.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170409073","title":"Jiangsu Hengrui's Subsidiary Receives Regulatory Nod for Diabetes Drug Application","url":"https://stock-news.laohu8.com/highlight/detail?id=1170409073","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170409073?lang=en_us&edition=fundamental","pubTime":"2026-09-02 16:52","pubTimestamp":1788339152,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals Co., Ltd. (SH: 600276) has announced that its subsidiary, Shandong Shengdi Pharmaceutical Co., Ltd., has received the Acceptance Notice from China's National Medical...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["600276","LU2097828557.USD","BK0188","LU2488822045.USD","BK0183","LU1064131003.USD","LU2097828474.EUR","LU1146622755.USD","LU2580892862.HKD","LU2328871848.SGD","LU0359202008.SGD","LU2495084118.USD","LU0359201885.HKD","01276","LU0405327148.USD","LU1023057109.AUD","LU1969619763.USD","LU1997245094.SGD","LU0405327494.USD","BK0028","LU1997244956.HKD","BK0196","BK0060","LU2543165471.USD","LU1328615791.USD","IPOS","LU1820825898.SGD","LU1997245177.USD","LU1655091616.SGD","LU1064130708.USD","LU0359201612.USD","LU1580142542.USD","LU1255011170.USD","LU2097828714.EUR","BK0239","LU2097828805.USD","LU2148510915.USD","LU2580892789.USD","BK0012","LU2097828631.EUR","LU2289578879.USD","LU1781817850.SGD","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100166191","title":"Movement Alert｜HENGRUI PHARMA Falls 3.05% in Regular Trading, Mid-Year Earnings Under Pressure Amid Broad Pharma Sector Weakness","url":"https://stock-news.laohu8.com/highlight/detail?id=1100166191","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100166191?lang=en_us&edition=fundamental","pubTime":"2026-08-31 10:10","pubTimestamp":1788142223,"startTime":"0","endTime":"0","summary":"On August 31, HENGRUI PHARMA fell 3.05% in regular trading, trading at 46.56 HKD/share, with turnover of approximately 56.25 million HKD. The decline came as the broader pharmaceuticals sector...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Hengrui Pharma Falls as JPMorgan Boosts Short Position","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133434643","title":"Hengrui Pharma's Interim Report Falls Flat: Legacy Blockbusters Fade as Revenue Posts First Half-Year Decline in Four Years","url":"https://stock-news.laohu8.com/highlight/detail?id=1133434643","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133434643?lang=en_us&edition=fundamental","pubTime":"2026-08-27 16:20","pubTimestamp":1787818843,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals Co.,Ltd. (SSE: 600276) recently released its interim report for the first half of 2026, and the numbers paint a less-than-rosy picture. During the reporting period,...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2097828805.USD","LU1064130708.USD","LU0359201885.HKD","BK0188","LU2328871848.SGD","BK0196","BK0060","BK1191","LU2097828474.EUR","LU0405327148.USD","LU1146622755.USD","LU1997245177.USD","01276","LU1255011170.USD","LU2097828714.EUR","LU1328615791.USD","LU1997244956.HKD","BK0028","LU0359201612.USD","BK0012","LU0359202008.SGD","LU1064131003.USD","LU2097828557.USD","BK0239","LU1997245094.SGD","LU2580892862.HKD","LU1580142542.USD","600276","LU2543165471.USD","LU1969619763.USD","LU1655091616.SGD","LU2580892789.USD","LU1023057109.AUD","LU1781817850.SGD","BK0183","LU0405327494.USD","LU1820825898.SGD","LU2148510915.USD","LU2495084118.USD","LU2289578879.USD","LU2488822045.USD","LU2097828631.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165601808","title":"Movement Alert｜HENGRUI PHARMA Rises 3.04% in Regular Trading, GIC Private Limited Consecutively Increases Stake to 17.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=1165601808","media":"Market Focus","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165601808?lang=en_us&edition=fundamental","pubTime":"2026-08-27 15:02","pubTimestamp":1787814123,"startTime":"0","endTime":"0","summary":"On August 27, HENGRUI PHARMA rose 3.04% in regular trading, trading at 48.12 HKD/share, with turnover of HKD 478 million.On the news front, Hong Kong Exchange disclosures revealed that Singapore...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"GIC Boosts Hengrui Pharma Stake to 17.19% as Shares Rise","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106227619","title":"Singapore Sovereign Fund Boosts Stake in Chinese Drugmaker with HK$185 Million Share Purchase","url":"https://stock-news.laohu8.com/highlight/detail?id=1106227619","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1106227619?lang=en_us&edition=fundamental","pubTime":"2026-08-27 08:10","pubTimestamp":1787789429,"startTime":"0","endTime":"0","summary":"Hong Kong stock exchange disclosures have revealed a notable transaction involving a major global institutional investor and a leading Chinese pharmaceutical company.On August 21, GIC Private...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1969619763.USD","LU2148510915.USD","BK0239","LU1820825898.SGD","LU1997244956.HKD","BK1191","LU1781817850.SGD","LU1023057109.AUD","LU0405327148.USD","LU0359202008.SGD","LU2097828631.EUR","LU0405327494.USD","LU2328871848.SGD","LU2097828557.USD","LU0359201612.USD","BK0196","LU1580142542.USD","LU2097828714.EUR","LU2543165471.USD","BK0183","LU2495084118.USD","LU1997245094.SGD","LU1997245177.USD","01276","LU2488822045.USD","LU1064130708.USD","BK0060","BK0188","LU1328615791.USD","BK0028","LU2097828474.EUR","BK0012","LU2580892789.USD","EWH","LU1064131003.USD","LU0359201885.HKD","LU2580892862.HKD","600276","LU1255011170.USD","LU1146622755.USD","LU2289578879.USD","BK4104","LU1655091616.SGD","LU2097828805.USD","GIC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662790837","title":"JPMorgan Chase & Co.'S Short Position in H-Shares of Jiangsu Hengrui Pharmaceuticals Co., Ltd. Increases to 3.72% on August 21 from 2.57% - HKEX","url":"https://stock-news.laohu8.com/highlight/detail?id=2662790837","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662790837?lang=en_us&edition=fundamental","pubTime":"2026-08-26 18:28","pubTimestamp":1787740118,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nFWN44N0FH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1064130708.USD","600276","LU1580142542.USD","LU2580892862.HKD","BK0183","LU1064131003.USD","BK1191","LU2495084118.USD","BK0012","BK0188","LU2580892789.USD","LU1146622755.USD","LU2097828474.EUR","LU0405327494.USD","LU1328615791.USD","LU2097828631.EUR","LU2328871848.SGD","LU1997245094.SGD","LU2097828714.EUR","LU2543165471.USD","BK0239","LU2488822045.USD","01276","LU1023057109.AUD","LU1655091616.SGD","LU1820825898.SGD","LU0359202008.SGD","LU0405327148.USD","BK0028","LU1781817850.SGD","LU0359201612.USD","LU2148510915.USD","LU1969619763.USD","LU2289578879.USD","LU2097828805.USD","LU1997244956.HKD","BK0060","BK0196","LU2097828557.USD","LU0359201885.HKD","LU1255011170.USD","LU1997245177.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100671669","title":"Singapore's GIC Boosts Stake in Hengrui Pharma With HK$185 Million Share Purchase","url":"https://stock-news.laohu8.com/highlight/detail?id=1100671669","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100671669?lang=en_us&edition=fundamental","pubTime":"2026-08-25 19:30","pubTimestamp":1787657435,"startTime":"0","endTime":"0","summary":"Hong Kong exchange filings reveal that on August 20, GIC Private Limited acquired an additional 3.6586 million shares of HENGRUI PHARMA (01276) at an average price of HK$50.5655 per share, bringing...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0060","LU2148510915.USD","BK4104","LU1255011170.USD","BK0188","LU1655091616.SGD","LU2097828805.USD","LU2097828474.EUR","EWH","LU2097828557.USD","LU1064130708.USD","LU1997245094.SGD","LU2488822045.USD","LU1146622755.USD","LU1328615791.USD","LU0359201885.HKD","LU1781817850.SGD","BK0196","LU1064131003.USD","BK1191","LU1969619763.USD","LU2289578879.USD","LU2580892862.HKD","600276","LU2328871848.SGD","GIC","LU1023057109.AUD","BK0183","LU2580892789.USD","LU1820825898.SGD","BK0239","BK0012","01276","LU0359202008.SGD","LU2097828714.EUR","LU2097828631.EUR","LU0405327148.USD","LU0359201612.USD","LU1580142542.USD","BK0028","LU1997245177.USD","LU0405327494.USD","LU2495084118.USD","LU1997244956.HKD","LU2543165471.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143746816","title":"HENGRUI PHARMA: GIC Private Limited Acquires Shares, Long Position Rises to 15.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=1143746816","media":"HK Disclosure","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143746816?lang=en_us&edition=fundamental","pubTime":"2026-08-25 17:16","pubTimestamp":1787649406,"startTime":"0","endTime":"0","summary":"GIC Private Limited bought 3.66 million shares of HENGRUI PHARMA at an average of HKD 50.5655 per share on August 20, 2026, involving about HKD 185.00 million.Prior to the acquisition, GIC Private...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662678835","title":"Chinese Drug Regulator Accepts Hengrui Pharma's Drug Marketing Application for HRG2010 Capsules","url":"https://stock-news.laohu8.com/highlight/detail?id=2662678835","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662678835?lang=en_us&edition=fundamental","pubTime":"2026-08-25 10:43","pubTimestamp":1787625833,"startTime":"0","endTime":"0","summary":"China's National Medical Products Administration accepted Jiangsu Hengrui Pharmaceuticals' (SHA:600276, HKG:1276) drug marketing authorization application for HRG2010 capsules, according to a Shanghai bourse filing on Tuesday.The drug is used for the treatment of Parkinson's disease.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0359201612.USD","LU1023057109.AUD","LU0359201885.HKD","01276","LU2543165471.USD","LU0359202008.SGD","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156894355","title":"HENGRUI PHARMA's HRG2010 Capsule Marketing Application Accepted by NMPA","url":"https://stock-news.laohu8.com/highlight/detail?id=1156894355","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156894355?lang=en_us&edition=fundamental","pubTime":"2026-08-24 22:24","pubTimestamp":1787581455,"startTime":"0","endTime":"0","summary":"HENGRUI PHARMA (01276) has announced that its marketing authorization application for the HRG2010 capsule has been formally accepted by China's National Medical Products Administration (NMPA),...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2580892862.HKD","LU2580892789.USD","IPOS","BK0060","LU1997244956.HKD","LU2543165471.USD","LU2289578879.USD","LU2328871848.SGD","BK0028","LU1023057109.AUD","LU2488822045.USD","LU1655091616.SGD","LU1997245177.USD","BK0012","LU2097828557.USD","LU2097828631.EUR","LU0359202008.SGD","LU1064131003.USD","BK0239","LU0405327148.USD","LU1064130708.USD","BK0188","LU0359201885.HKD","LU1580142542.USD","LU0359201612.USD","LU2097828714.EUR","LU1328615791.USD","BK0196","BK0183","LU2097828474.EUR","LU1781817850.SGD","LU1969619763.USD","LU1997245094.SGD","600276","LU1146622755.USD","LU1820825898.SGD","LU2495084118.USD","LU1255011170.USD","LU0405327494.USD","BK1191","LU2097828805.USD","01276","LU2148510915.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661446273","title":"Nomura Adjusts Jiangsu Hengrui Pharmaceuticals' Price Target to HK$82.18 From HK$87.49, Keeps at Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2661446273","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661446273?lang=en_us&edition=fundamental","pubTime":"2026-08-24 19:13","pubTimestamp":1787570024,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals (HKG:1276) has an average rating of overweight and mean price target of HK$81.15, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and eco","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1191","LU1023057109.AUD","LU0359202008.SGD","LU2543165471.USD","LU0359201885.HKD","01276","LU0359201612.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125046383","title":"Hengrui Pharma's Half-Year Report: Heavy Spending Fails to Drive Growth as Former Sector Leader Struggles with Revenue Without Profit Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=1125046383","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125046383?lang=en_us&edition=fundamental","pubTime":"2026-08-24 15:46","pubTimestamp":1787557589,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals Co., Ltd. (SH: 600276) unveiled its half-year financial report in August 2026, and the mid-year scorecard, which had generated considerable market anticipation, fell...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2097828714.EUR","LU1820825898.SGD","LU1655091616.SGD","BK1161","LU0359201612.USD","LU1781817850.SGD","LU2097828631.EUR","LU0359201885.HKD","LU1064130708.USD","01276","LU2097828805.USD","LU1023057109.AUD","LU1997245094.SGD","BK1191","LU0405327148.USD","LU2097828557.USD","BK0028","LU2543165471.USD","LU1997244956.HKD","159938","BK0012","LU1146622755.USD","LU1064131003.USD","BK1574","LU1328615791.USD","BK0183","LU1580142542.USD","BK0196","BK1515","BK0060","LU2495084118.USD","600276","LU0405327494.USD","LU2097828474.EUR","LU1255011170.USD","LU2580892862.HKD","09939","LU2148510915.USD","LU1997245177.USD","LU2488822045.USD","LU2580892789.USD","LU2289578879.USD","BK0188","BK0239","LU0359202008.SGD","LU2328871848.SGD","LU1969619763.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102739299","title":"Movement Alert｜HENGRUI PHARMA Falls 3.03% in Regular Trading, BOCOM International Cuts Target Price Citing Continued Pressure on Legacy Products","url":"https://stock-news.laohu8.com/highlight/detail?id=1102739299","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102739299?lang=en_us&edition=fundamental","pubTime":"2026-08-24 10:41","pubTimestamp":1787539319,"startTime":"0","endTime":"0","summary":"On August 24, HENGRUI PHARMA fell 3.03% in regular trading, trading at HKD 46.74/share, with turnover of HKD 327 million. The decline was triggered by BOCOM International issuing a research note on...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"BOCOM International Cuts Hengrui Pharma Target Price","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157060014","title":"Hengrui Pharma's Growth Architecture Shifts: Second Growth Engine Accelerates as Global Valuation Framework Expands","url":"https://stock-news.laohu8.com/highlight/detail?id=1157060014","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157060014?lang=en_us&edition=fundamental","pubTime":"2026-08-23 21:06","pubTimestamp":1787490393,"startTime":"0","endTime":"0","summary":"On August 19, Hengrui Pharma (01276) delivered a resilient first-half earnings report. During the period, the company recorded operating revenue of RMB 15.456 billion, with net profit attributable to...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1781817850.SGD","BK0012","LU1023057109.AUD","LU1255011170.USD","600276","LU2328871848.SGD","LU0405327494.USD","LU0405327148.USD","LU0359201885.HKD","LU2580892789.USD","BK0028","LU1820825898.SGD","BK0060","LU2097828474.EUR","BK0196","LU2289578879.USD","01276","LU2543165471.USD","LU1969619763.USD","LU1997244956.HKD","LU1997245177.USD","LU2097828805.USD","LU2488822045.USD","LU2097828631.EUR","LU2097828557.USD","LU0359201612.USD","LU2097828714.EUR","LU2495084118.USD","LU1997245094.SGD","LU2148510915.USD","BK1191","LU2580892862.HKD","LU1146622755.USD","LU1064131003.USD","LU1655091616.SGD","BK0239","LU1580142542.USD","LU1328615791.USD","LU1064130708.USD","LU0359202008.SGD","BK0183","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661212256","title":"Hengrui Pharma Gets Nod to Trial SHR-8203 Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=2661212256","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661212256?lang=en_us&edition=fundamental","pubTime":"2026-08-21 10:08","pubTimestamp":1787278105,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals  received approval from China's National Medical Products Administration for the clinical trial of SHR-8203 injection, according to a Shanghai bourse filing on Friday.The drug will be tested as a monotherapy for advanced solid tumors.The Chinese pharmaceutical company's Shanghai shares dropped 3% during the morning trade.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2543165471.USD","LU0359201612.USD","LU0359201885.HKD","BK1191","LU0359202008.SGD","01276","LU1023057109.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661256285","title":"Hengrui Pharma Unit Gets China Nod for Lupus Drug Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2661256285","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661256285?lang=en_us&edition=fundamental","pubTime":"2026-08-21 10:05","pubTimestamp":1787277919,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals  (SHA:600276) unit Guangdong Hengrui Medicine obtained approval from China's drug regulator to begin clinical trials for SHR-7012 injection.SHR-7012 targets cutaneous lupus erythematosus, according to a Thursday aftermarket filing.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1023057109.AUD","LU2543165471.USD","LU0359201885.HKD","BK1191","01276","LU0359202008.SGD","LU0359201612.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175051703","title":"Movement Alert｜HENGRUI PHARMA Declines 3.18% in Regular Trading, Extending Sell-Off on Weak H1 Earnings Quality","url":"https://stock-news.laohu8.com/highlight/detail?id=1175051703","media":"Market Focus","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175051703?lang=en_us&edition=fundamental","pubTime":"2026-08-21 09:42","pubTimestamp":1787276522,"startTime":"0","endTime":"0","summary":"On August 21, HENGRUI PHARMA declined 3.18% in regular trading, trading at 47.66 HKD/share with turnover of approximately 109 million HKD, extending the prior session's 8.55% selloff.The decline...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Hengrui Pharma Extends Decline on Weak Cash Flow and Core Profit","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200,"code":"91000000","status":"200"}]}}